GOODWILL AND INTANGIBLE ASSETS

12 Months Ended

Dec. 31, 2015

Goodwill and Intangible Assets Disclosure [Abstract]

The gross carrying amounts and net book values of the Company's intangible assets are as follows (in thousands):



	Carrying Value, Gross							Accumulated Amortization									Intangible Assets, Net				Weighted
	December 31, 2014		(Decrease)/Increase (1)			December 31, 2015		December 31, 2014			(Increase)/Decrease (2)			December 31, 2015			December 31, 2014		December 31, 2015		Average Useful Life
Customer relationships	$	75,229	$	(1,006	)	$	74,223	$	(27,301	)	$	(4,551	)	$	(31,852	)	$	47,928	$	42,371	11 years
Developed technologies	75,194		(1,856		)	73,338		(29,367		)	(4,592		)	(33,959		)	45,827		39,379		10 years
Trademarks and tradenames	17,793		(30		)	17,763		(9,778		)	(3,365		)	(13,143		)	8,015		4,620		5 years
Other contractual agreements	2,978		(89		)	2,889		(2,978		)	89			(2,889		)	—		—		2 years
Licenses	81,762		546			82,308		(77,349		)	(931		)	(78,280		)	4,413		4,028		14 years
Total intangible assets subject to amortization	252,956		(2,435		)	250,521		(146,773		)	(13,350		)	(160,123		)	106,183		90,398
In-process research and development	—		12,000			12,000		—			—			—			—		12,000		N.A.
Total intangible assets, net	$	252,956	$	9,565		$	262,521	$	(146,773	)	$	(13,350	)	$	(160,123	)	$	106,183	$	102,398


(1)	Includes additions in connection with the Acquisition in 2015 and a decrease in carrying value of $3.9 million related to foreign currency translation.


(2)	The impact of foreign currency translation on accumulated amortization was a decrease of $1.0 million.

The expected future annual amortization expense of the Company's intangible assets is as follows (in thousands):



	Amortization
For the Year Ending December 31,	Expense
2016	$	13,433
2017	11,764
2018	10,189
2019	10,179
2020	10,179
Thereafter	34,654
Total	$	90,398

The Company recognized goodwill of $2.6 million and $157.1 million in connection with the Acquisition in 2015 and the eBioscience acquisition in 2012, respectively. Information in regards to changes in the Company's goodwill as of December 31, 2015 is as follows (in thousands):



Balance at December 31, 2014	$	156,178
Goodwill from acquisition	2,559
Effects of foreign currency change	(4,198		)
Balance at December 31, 2015	$	154,539

During the year ended December 31, 2015, the Company concluded that there were no indicators of impairment during its annual impairment test of goodwill and the balance as of December 31, 2015 is expected to be recoverable.

- Definition

The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.

+ References + Details